NCT06041399

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,400 (estimated)
• Sponsor: First Affiliated Hospital of Wenzhou Medical University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The goal of this observational study is to explore the relationship between related blood indicators and diabetic peripheral neuropathy.

Detailed description

This is a multi-center(about five), randomized, double-blind, placebo-controlled clinical trial with over 1000 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood biochemical markers and electromyography. All participants provided their written informed consent to participate in this study.The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University(KY-2022-R009).

Conditions

• Diabetic Peripheral Neuropathy

Interventions

Type	Name	Description
DRUG	hypoglycemic Agents(metformin)	patients treated with hypoglycemic Agents(metformin)
DRUG	lipid-lowering drug(Statin)	patients treated with lipid-lowering drug(Statin)

Timeline

• Start date: 2012-02-01
• Primary completion: 2022-12-18
• Completion: 2025-01-02
• First posted: 2023-09-18
• Last updated: 2023-09-18

Locations

1 site across 1 country: China